학술논문
A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
Document Type
Article
Author
Source
In: Frontiers in Medicine . (Frontiers in Medicine, 8 September 2022, 9)
Subject
Language
English
ISSN
2296858X